<?xml version="1.0" encoding="UTF-8"?>
<ref id="B23-pharmaceutics-11-00021" class="ref">
 <label class="label">23.</label>
 <element-citation publication-type="journal" class="element-citation">
  <person-group person-group-type="author" class="person-group">
   <name class="name">
    <surname class="surname">Vemavarapu</surname>
    <given-names class="given-names">C.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Mollan</surname>
    <given-names class="given-names">M.J.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Lodaya</surname>
    <given-names class="given-names">M.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Needham</surname>
    <given-names class="given-names">T.E.</given-names>
   </name>
  </person-group>
  <article-title class="article-title">Design and process aspects of laboratory scale SCF particle formation systems</article-title>
  <source class="source">Int. J. Pharm.</source>
  <year class="year">2005</year>
  <volume class="volume">292</volume>
  <fpage class="fpage">1</fpage>
  <lpage class="lpage">16</lpage>
  <pub-id pub-id-type="doi" class="pub-id">10.1016/j.ijpharm.2004.07.021</pub-id>
  <?supplied-pmid 15725549?>
  <pub-id pub-id-type="pmid" class="pub-id">15725549</pub-id>
 </element-citation>
</ref>
